Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs

March has seen a slew of executive hires, exits and layoffs across the healthcare industry. For instance, Flare Capital Partners, SCAN Group and Advocate Health named new executives. There were also layoffs at organizations including Oracle, Takeda and Blue Shield of California. The post Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs appeared…

Read More

Eli Lilly’s Neuro Prospects Expand to Sleep Science With $6.3B Centessa Acquisition

Centessa Pharmaceuticals’ cleminorexton is part of the orexin agonist drug class, which could introduce a new approach to the treatment of narcolepsy and other sleep disorders. Acquiring Centessa brings Eli Lilly into a group of clinical-stage orexin agonist drug developers that includes Takeda Pharmaceutical, Alkermes, and Eisai. The post Eli Lilly’s Neuro Prospects Expand to…

Read More

Device Cleaning Instructions – An Overlooked Safety Risk In Sterile Processing

By Andy Petrovich, National Vice President, Crothall Healthcare & Afif Eschiek, National Director, Crothall Healthcare Many sterile processing departments manage thousands of reusable devices from thousands of manufacturers, each with its unique reprocessing requirements. Hospitals rely on clear instructions for use (IFUs) to safely reprocess these medical devices. Yet inconsistent or impractical instructions continue to…

Read More

Healthcare’s Quiet Dependence on the “Possimpible”

By GANESH ASAITHAMBI In an episode of the sitcom How I Met Your Mother (HIMYM), Barney Stinson introduces a fictional word: possimpible. The possimpible combines “possible” and “impossible” and describes the extraordinary achievements by people who refuse to accept conventional limits. In modern healthcare, the possimpible is no longer a joke; it has quietly become…

Read More